Results
1 -
10 of
16
(Click
here to explore results)
- DNA Damage, DNA Repair and Disease: Volume 2, Chapter 28 The Role of PARP and the Therapeutic Potential of PARP Inhibitors in Cancer. N. J. Curtin
, 2021
, Volume 2
, Pages 319-360
- DNA Damage, DNA Repair and Disease: Volume 2, Chapter 26 Evolving DNA Repair Targets for Cancer Therapy. M. T. Sadiq, S. Madhusudan
, 2021
, Volume 2
, Pages 254-285
- Computational Tools for Chemical Biology, Chapter 13 The Polypharmacology Gap Between Chemical Biology and Drug Discovery. Albert A. Antolin, Jordi Mestres
, 2018
, Pages 349-370
- Conference on Drug Design and Discovery Technologies, Design and Synthesis of Novel Poly ADP-ribose Polymerase 1 (PARP1) Inhibitors for the Treatment of Solid Tumors. J. Priyancy, D. P. Bhumika
, 2020
, Pages 31-35
- MALDI Mass Spectrometry Imaging: From Fundamentals to Spatial Omics, Chapter 14 MALDI Mass Spectrometry Imaging in Drug Discovery and Development. Jeremy A. Barry, Peter S. Marshall, M. Reid Groseclose
, 2022
, Pages 321-358
- Cytotoxic Payloads for Antibody–Drug Conjugates, CHAPTER 8 Topoisomerase Inhibitors as Antibody–Drug Conjugate (ADC) Payloads. Serengulam V. Govindan, Thomas M. Cardillo, David M. Goldenberg
, 2019
, Pages 166-186
- The Discovery and Utility of Chemical Probes in Target Discovery, CHAPTER 10 Assays to Characterize the Cellular Pharmacology of a Chemical Probe. Jakub Stefaniak, Sébastien R. G. Galan, Kilian V. M. Huber
, 2021
, Pages 247-275
- Phenotypic Drug Discovery, Chapter 1 Phenotypic Drug Discovery: History, Evolution, Future. David C. Swinney
, 2021
, Pages 1-19
- Phenotypic Drug Discovery, Chapter 5 Contemporary Techniques for Target Deconvolution and Mode of Action Elucidation. Markus Schirle, Jeremy L. Jenkins
, 2021
, Pages 83-103
- Sustainable Synthesis of Pharmaceuticals: Using Transition Metal Complexes as Catalysts, Chapter 4 Carbonylation Reactions in the Synthesis of Pharmaceutically Active Compounds. R. Skoda-Földes, L. Kollár
, 2018
, Pages 40-65